U.S. Food and Drug Administration
Generic Drugs Used in the Treatment of HIV Infection
May 2007
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
| Generic Name |
Manufacturer Name |
Approval Date |
Time to Approval |
didanosine (ddI)
Delayed Release capsules |
Barr Laboratories, Inc. |
03-Dec-04 |
6 months |
didanosine
(ddI)
for oral solution
(pediatric powder), 10 mg/mL |
Aurobindo Pharma Limited |
08-March-07 |
14 months |
| Oral Solution -- zidovudine,
AZT, azidothymidine, ZDV (Pediatric formulation - 50 mg/ 5 mL) |
Aurobindo Pharma Limited |
19-Sep-05 |
6 months |
| zidovudine, AZT, azidothymidine, ZDV (300
mg tablet) |
Aurobindo Pharma Limited |
19-Sep-05 |
10 months |
| zidovudine, AZT, azidothymidine, ZDV (300 mg
tablet) |
Ranbaxy Laboratories Limited |
19-Sep-05 |
11 months |
| zidovudine, AZT, azidothymidine, ZDV (300 mg
tablet) |
Roxane Laboratories |
19-Sep-05 |
24 months |
| zidovudine, AZT, azidothymidine, ZDV (100 mg
capsule) |
Aurobindo Pharma LTD. |
27-March--06 |
4 months |
| zidovudine, AZT, azidothymidine, ZDV (100 mg
capsule) |
Cipla Limited |
23-May-2007 |
11 months |
This article was provided by
U.S. Food and Drug Administration.
